Genomics

Dataset Information

0

Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [Myc_CaP]

ABSTRACT: Here we show that low dose Oxali, and to a lesser extent other platinoids, can uniquely activate the transcriptional program that controls MHCI antigen processing and presentation. Activation of this program correlates with induction of histone acetylation and enhanced chromatin accessibility. Oxaliplatin also induces NF-kB dependent IFNg receptor 2 (IFNgR2) thereby augmenting the tumor response to exogenous IFNg produced by reinvigorated effector CD8+ T cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE126269 | GEO | 2021/02/01

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [AT_MC]
2021-02-01 | GSE126287 | GEO
Transcriptomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [TRAMP]
2021-02-01 | GSE126273 | GEO
Transcriptomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [CCO19-MC]
2021-02-01 | GSE126274 | GEO
Transcriptomics p300/CBP mediated activation of MHCI machinery and IFNg receptor loci controls chemoimmunotherapy
2021-02-01 | GSE151611 | GEO
Genomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes
| PRJNA521479 | ENA
Transcriptomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes
2021-02-01 | GSE126288 | GEO
Genomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [TRAMP]
| PRJNA521468 | ENA
Genomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [Myc_CaP]
| PRJNA521465 | ENA
Genomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [AT_MC]
| PRJNA521486 | ENA
Genomics Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [CCO19-MC]
| PRJNA521467 | ENA